New imaging test spots rare nerve disease
NCT ID NCT03019029
First seen Mar 17, 2026 · Last updated May 15, 2026 · Updated 13 times
Summary
This study tested whether a combined PET/MR scan using a radioactive tracer called F-18 florbetapir can detect amyloid deposits in the nerves of people with systemic amyloidosis. Eight adults with confirmed nerve amyloidosis or other nerve diseases were scanned to see if the tracer highlights amyloid. The goal was to improve diagnosis of this rare condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYLOIDOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.